The Australian Cancer Research Foundation (ACRF) is thrilled that funding to medical research through the NHMRC will be maintained in the 2011/2012 budget.
“It is wonderful to see the government recognise the vital need for continued investment in medical research in Australia,” said ACRF Chief Executive, David Brettell.
“It would have been a huge shame to interrupt the momentum of such vital research initiatives.”
To highlight the growing need for research dollars, ACRF has just received grant applications totaling $50 million. These grants provide seed funding to leading cancer research institutes across Australia.
“We’re excited to report a 50% increase in the number of applications to ACRF grants compared to last year. It’s a powerful endorsement of the need for renewed funding to medical research in Australia.
“We’ve seen a boom in applications from cancer research institutes in Melbourne – 7 in total – with some of the best research centres in SA, QLD, NSW and TAS also applying for funding. It’s an exciting time for research right across Australia.
“Cancer affects one in three Australians, but the research we are funding finds new answers every day and gives us all hope for the future.”
ACRF is one of Australia’s largest private funders of world-class cancer research projects in Australia. Every dollar of every donation ACRF receives funds cancer research.
ACRF seed-funding has supported the development of the cervical cancer vaccine, a multi-million dollar robot at the Children’s Cancer Institute Australia which accelerates years of work into just days, and many other projects across Australia, which are moving closer and closer to finding answers in the fight against cancer.